Lübbert M - Search Results

1

Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy.

Döhner H, Lübbert M, Fiedler W, Fouillard L, Haaland A, Brandwein JM, Lepretre S, Reman O, Turlure P, Ottmann OG, Müller-Tidow C, Krämer A, Raffoux E, Döhner K, Schlenk RF, Voss F, Taube T, Fritsch H, Maertens J. Döhner H, et al. Among authors: lubbert m. Blood. 2014 Aug 28;124(9):1426-33. doi: 10.1182/blood-2014-03-560557. Epub 2014 Jul 8. Blood. 2014. PMID: 25006120 Free PMC article. Clinical Trial.

2

Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment.

Daskalakis M, Nguyen TT, Nguyen C, Guldberg P, Köhler G, Wijermans P, Jones PA, Lübbert M. Daskalakis M, et al. Among authors: lubbert m. Blood. 2002 Oct 15;100(8):2957-64. doi: 10.1182/blood.V100.8.2957. Blood. 2002. PMID: 12351408 Free article.

3

Efficacy and safety of imatinib mesylate (Glivec) in combination with interferon-alpha (IFN-alpha) in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL).

Wassmann B, Scheuring U, Pfeifer H, Binckebanck A, Käbisch A, Lübbert M, Leimer L, Gschaidmeier H, Hoelzer D, Ottmann OG. Wassmann B, et al. Among authors: lubbert m. Leukemia. 2003 Oct;17(10):1919-24. doi: 10.1038/sj.leu.2403093. Leukemia. 2003. PMID: 14513038 Clinical Trial.

4

Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate.

Pfeifer H, Wassmann B, Hofmann WK, Komor M, Scheuring U, Brück P, Binckebanck A, Schleyer E, Gökbuget N, Wolff T, Lübbert M, Leimer L, Gschaidmeier H, Hoelzer D, Ottmann OG. Pfeifer H, et al. Among authors: lubbert m. Clin Cancer Res. 2003 Oct 15;9(13):4674-81. Clin Cancer Res. 2003. PMID: 14581336

5

Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias.

Krauter J, Gorlich K, Ottmann O, Lubbert M, Dohner H, Heit W, Kanz L, Ganser A, Heil G. Krauter J, et al. Among authors: lubbert m. J Clin Oncol. 2003 Dec 1;21(23):4413-22. doi: 10.1200/JCO.2003.03.166. J Clin Oncol. 2003. PMID: 14645432

6

Risk-adapted induction and consolidation therapy in adults with de novo AML aged </= 60 years: results of a prospective multicenter trial.

Heil G, Krauter J, Raghavachar A, Bergmann L, Hoelzer D, Fiedler W, Lübbert M, Noens L, Schlimok G, Arnold R, Kirchner H, Ganser A. Heil G, et al. Among authors: lubbert m. Ann Hematol. 2004 Jun;83(6):336-44. doi: 10.1007/s00277-004-0853-z. Epub 2004 Mar 18. Ann Hematol. 2004. PMID: 15034758 Clinical Trial.

7

CXCR4 is a prognostic marker in acute myelogenous leukemia.

Spoo AC, Lübbert M, Wierda WG, Burger JA. Spoo AC, et al. Among authors: lubbert m. Blood. 2007 Jan 15;109(2):786-91. doi: 10.1182/blood-2006-05-024844. Epub 2006 Aug 3. Blood. 2007. PMID: 16888090 Free article.

8

Advances in the treatment of acute myeloid leukemia: from chromosomal aberrations to biologically targeted therapy.

Lübbert M, Müller-Tidow C, Hofmann WK, Koeffler HP. Lübbert M, et al. J Cell Biochem. 2008 Aug 15;104(6):2059-70. doi: 10.1002/jcb.21770. J Cell Biochem. 2008. PMID: 18613031 Review.

9

Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia.

Damm F, Heuser M, Morgan M, Yun H, Grosshennig A, Göhring G, Schlegelberger B, Döhner K, Ottmann O, Lübbert M, Heit W, Kanz L, Schlimok G, Raghavachar A, Fiedler W, Kirchner H, Döhner H, Heil G, Ganser A, Krauter J. Damm F, et al. Among authors: lubbert m. J Clin Oncol. 2010 Feb 1;28(4):578-85. doi: 10.1200/JCO.2009.23.0342. Epub 2009 Dec 28. J Clin Oncol. 2010. PMID: 20038731

10

High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.

Gröschel S, Lugthart S, Schlenk RF, Valk PJ, Eiwen K, Goudswaard C, van Putten WJ, Kayser S, Verdonck LF, Lübbert M, Ossenkoppele GJ, Germing U, Schmidt-Wolf I, Schlegelberger B, Krauter J, Ganser A, Döhner H, Löwenberg B, Döhner K, Delwel R. Gröschel S, et al. Among authors: lubbert m. J Clin Oncol. 2010 Apr 20;28(12):2101-7. doi: 10.1200/JCO.2009.26.0646. Epub 2010 Mar 22. J Clin Oncol. 2010. PMID: 20308656

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

360 results

Search Page